Nicholas Investment Partners, LP

Holdings History for KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)

Symbol: KALV on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2024		-0.23%	$0	0	-184,358	-100%	$15.76	Q3 2024
30 Jun 2024	0.23%	+0%	$2,171,737	184,358	+1,714	+0.94%	$11.78	Q2 2024
31 Mar 2024	0.22%	+0.22%	$2,166,158	182,644	+182,644	NEW	$11.86	Q1 2024
31 Dec 2021		-0.28%	$0	0	-217,389	-100%	$15.76	Q4 2021
30 Sep 2021	0.28%	-0.55%	$3,794,000	217,389	-433,514	-67%	$17.45	Q3 2021
30 Jun 2021	0.98%	+0.09%	$15,596,000	650,903	+56,773	+9.6%	$23.96	Q2 2021
31 Mar 2021	1.1%	+1.1%	$15,263,000	594,130	+594,130	NEW	$25.69	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.